Add to ORKGauThOr’s VIew Immune responses against established neoplasms are often dysfunctional due the fact that cancer cells are poorly immunogenic and highly immunoevasive.1 Various studies have demonstrated that the elicitation of anticancer immune responses along with the death of malignant cells can provide long-lasting therapeutic effects.1 Unfortunately, most cytotoxic therapies are incapable of reinstating the immunogenicity of cancer cells.2 However, it has recently been observed that some anticancer agents including assorted chemotherapeutics, hypericin-based photodynamic therap